low potency first generation anti-psychotic

-more effective at 5-HT receptos

-more effective on negative symptoms

Atypical antipsychotic

-lower risk of tardive dyskinesia and extrapyramidal efx

-D1 and D4 antagonist

-Potent 5-HT2 antagonist

*severe agranulocytosis

Atypical antipsychotic

-partial D2 agonist

-milder anti-cholinergic

Atypical Antipsychoitc

-Can cause significant weight gain (not good for DM)

Atypical antipsychotic

*potent a-adronergic agonist

abuse potential

Atypical antipsychotic

-Higher incidence of extrapyramidal efx (not for parkinsons)

-Prolongs QT interval

-^ prolactin

Atypical antipsychotic

-Modest SSRI activity

-Prolongs QT

-No weight gain